Literature DB >> 8994797

Antibiotic resistance: a view from the pharmaceutical industry.

R P Bax1.   

Abstract

The development of new antibiotics has been successful in significantly reducing morbidity and mortality. With increasing use there has occurred an increase in antibiotic resistance but not a parallel increase in new agents with significantly improved spectrum of activity. Without concerted action from the pharmaceutical industry, physicians, academia, health care providers, and governments, the prospects look gloomy.

Mesh:

Substances:

Year:  1997        PMID: 8994797     DOI: 10.1093/clinids/24.supplement_1.s151

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Development of Tyrocidine A analogues with improved antibacterial activity.

Authors:  Michael A Marques; Diane M Citron; Clay C Wang
Journal:  Bioorg Med Chem       Date:  2007-08-11       Impact factor: 3.641

Review 2.  Regulating the use of antibiotics in the community.

Authors:  C Carbon; R P Bax
Journal:  BMJ       Date:  1998-09-05

3.  Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy.

Authors:  J K Thomas; A Forrest; S M Bhavnani; J M Hyatt; A Cheng; C H Ballow; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

Review 4.  Quinolone use in the developing world: state of the art.

Authors:  T E Tupasi
Journal:  Drugs       Date:  1999       Impact factor: 9.546

5.  Identification of Bacterial Membrane Selectivity of Romo1-Derived Antimicrobial Peptide AMPR-22 via Molecular Dynamics.

Authors:  Hana Kim; Young Do Yoo; Gi Young Lee
Journal:  Int J Mol Sci       Date:  2022-07-03       Impact factor: 6.208

6.  Antimicrobial activity and mechanism of action of Nu-3, a protonated modified nucleotide.

Authors:  Shanping Cao; Lun-Quan Sun; Ming Wang
Journal:  Ann Clin Microbiol Antimicrob       Date:  2011-01-14       Impact factor: 3.944

Review 7.  Opinion: the clinical use of selective digestive decontamination.

Authors:  M H Kollef
Journal:  Crit Care       Date:  2000-10-02       Impact factor: 9.097

8.  Dispensing of non-prescribed antibiotics in Jordan.

Authors:  Ammar Almaaytah; Tareq L Mukattash; Julia Hajaj
Journal:  Patient Prefer Adherence       Date:  2015-09-30       Impact factor: 2.711

9.  Balteatide: a novel antimicrobial decapeptide from the skin secretion of the purple-sided leaf frog, Phyllomedusa baltea.

Authors:  Lilin Ge; Xiaole Chen; Chengbang Ma; Mei Zhou; Xinping Xi; Lei Wang; Anwei Ding; Jinao Duan; Tianbao Chen; Chris Shaw
Journal:  ScientificWorldJournal       Date:  2014-06-26

10.  There is no market for new antibiotics: this allows an open approach to research and development.

Authors:  Dana M Klug; Fahima I M Idiris; Mark A T Blaskovich; Frank von Delft; Christopher G Dowson; Claas Kirchhelle; Adam P Roberts; Andrew C Singer; Matthew H Todd
Journal:  Wellcome Open Res       Date:  2021-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.